Healthcare -
Biotechnology - NASDAQ - US
$ 1.8
-2.7 %
$ 393 M
Market Cap
-8.18
P/E
AKBA - INTEREST INCOME & EXPENSE
Interest Income & Expense AKBA - Akebia Therapeutics, Inc.
6.03 M
LAST VALUE
-44.99%
2 YEAR CAGR
-0.40%
5 YEAR CAGR
23.97%
10 YEAR CAGR